DOJ, SEC Expand FCPA Probe into Eli Lilly

Pharmaceutical giant Eli Lilly revealed in a filing Monday that its activities in several countries are now under scrutiny. The Securities and Exchange Commission began investigating Lilly's operations in Poland in 2003.

Get unlimited access to all Global Investigations Review content